Epilepsia Open

Article	Citations
Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group	139
EEG findings in acutely ill patients investigated for SARS‐CoV‐2/COVID‐19: A small case series preliminary report	110
Brain‐responsive corticothalamic stimulation in the pulvinar nucleus for the treatment of regional neocortical epilepsy: A case series	48
Managing depression and anxiety in people with epilepsy: A survey of epilepsy health professionals by the ILAE Psychology Task Force	42
Proposal to optimize evaluation and treatment of Febrile infection‐related epilepsy syndrome (FIRES): A Report from FIRES workshop	33
Guidance on Dravet syndrome from infant to adult care: Road map for treatment planning in Europe	30
Addressing neuropsychological diagnostics in adults with epilepsy: Introducing the International Classification of Cognitive Disorders in Epilepsy: The IC CODE Initiative	30
FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force	28
Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open‐label Study 342 (FREED	26
COX‐2/PGE2 axis regulates hippocampal BDNF/TrkB signaling via EP2 receptor after prolonged seizures	26
Antiepileptogenesis and disease modification: Progress, challenges, and the path forward—Report of the Preclinical Working Group of the 2018 NINDS‐sponsored antiepileptogenesis and disease modificatio	26
Management practices for West syndrome in South Asia: A survey study and meta‐analysis	25
The gut microbiome in drug‐resistant epilepsy	25
Global Survey of Guidelines for the Management of Epilepsy in Pregnancy: A report from the International League Against Epilepsy Task Force on Women and Pregnancy	19
Improving the effectiveness of ANT DBS therapy for epilepsy with optimal current targeting	19
Phenobarbital as alternate anticonvulsant for organophosphate‐induced benzodiazepine‐refractory status epilepticus and neuronal injury	19
Why child neurologists talk about SUDEP: Results from two cross‐sectional surveys	18
Serotonin receptors in epilepsy: Novel treatment targets?	18
Brain‐responsive neurostimulation treatment in patients with GAD65 antibody–associated autoimmune mesial temporal lobe epilepsy	17
Add‐on cannabidiol significantly decreases seizures in 3 patients with SYNGAP1 developmental and epileptic encephalopathy	17
Glymphatic system dysfunction in temporal lobe epilepsy patients with hippocampal sclerosis	17
Antiepileptogenesis and disease modification: Clinical and regulatory issues	17
Impact of diagnostic delay on seizure outcome in newly diagnosed focal epilepsy	16
Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program	16
A retrospective, real‐world experience of perampanel monotherapy in patient with first new onset focal seizure: A Thailand experience	15

Epileptic spasms in individuals with Down syndrome: A review of the current literature	15
Impact of the COVID‐19 lockdown on patients and families with Dravet syndrome	15
Sleep‐wake characteristics in a mouse model of severe traumatic brain injury: Relation to posttraumatic epilepsy	14
Ceribell EEG shortens seizure diagnosis and workforce time and is useful for COVID isolation	14
An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real‐world practice setting: A report from the Fenfluramine European	13
Driving a motor vehicle and psychogenic nonepileptic seizures: ILAE Report by the Task Force on Psychogenic Nonepileptic Seizures	13
Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges	13
Stereotactic laser interstitial thermal therapy corpus callosotomy for the treatment of pediatric drug‐resistant epilepsy	13
Acetazolamide: Old drug, new evidence?	13
Real‐world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study	13
Validation of EpiTRAQ, a transition readiness assessment tool for adolescents and young adults with epilepsy	13
PROVE: Retrospective, non‐interventional, Phase IV study of perampanel in real‐world clinical care of patients with epilepsy	13
Transporter hypothesis in pharmacoresistant epilepsies. Is it at the central or peripheral level?	13
A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway	12
On the clinical acceptance of black‐box systems for EEG seizure prediction	12
EEG datasets for seizure detection and prediction— A review	12
Daily listening to Mozart reduces seizures in individuals with epilepsy: A randomized control study	12
sEEG for expansion of a surgical epilepsy program: Safety and efficacy in 152 consecutive cases	11
Detection of anomalous high‐frequency events in human intracranial EEG	11
Developmental and epileptic encephalopathy: Personal utility of a genetic diagnosis for families	11
The opioid antagonist naltrexone decreases seizure‐like activity in genetic and chemically induced epilepsy models	11
One‐year cost‐effectiveness of callosotomy vs vagus nerve stimulation for drug‐resistant seizures in Lennox‐Gastaut Syndrome: A decision analytic model	11
Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman‐induced epileptogenesis and brain pathology in rats	11
Development and validation of the Epilepsy Self‐Stigma Scale	11
Newly diagnosed seizures assessed at two established first seizure clinics: Clinic characteristics, investigations, and findings over 11 years	11
How much time is enough? Establishing an optimal duration of recording for ambulatory video EEG	11
Medical treatment in infants and young children with epilepsy: Off‐label use of antiseizure medications. Survey Report of ILAE Task Force Medical Therapies in Children	10
Brain‐Responsive Neurostimulation for the treatment of adults with epilepsy in tuberous sclerosis complex: A case series	10
Coupling between infraslow activities and high‐frequency oscillations precedes seizure onset	10
The role of efflux transporters and metabolizing enzymes in brain and peripheral organs to explain drug‐resistant epilepsy	9
Post‐acute symptomatic seizure (PASS) clinic: A continuity of care model for patients impacted by continuous EEG monitoring	9
Dravet syndrome: A systematic literature review of the illness burden	9
Behavioral phenotypes of temporal lobe epilepsy	9
Long‐term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open‐label trial	9
Systemic and cerebrospinal fluid immune and complement activation in Ugandan children and adolescents with long‐standing nodding syndrome: A case‐control study	9
Sevoflurane as bridge therapy for plasma exchange and Anakinra in febrile infection–related epilepsy syndrome	8
Diurnal burden of spontaneous seizures in early epileptogenesis in the post‐kainic acid rat model of epilepsy	8
Availability, affordability, and quality of essential antiepileptic drugs in Lao PDR	8
Scalp HFO rates are higher for larger lesions	8
Classifying etiology of infantile spasms syndrome in resource‐limited settings: A study from the South Asian region	8
Screening of prototype antiseizure and anti‐inflammatory compounds in the Theiler's murine encephalomyelitis virus model of epilepsy	8
Therapeutic drug monitoring of perampanel in children diagnosed with epilepsy: Focus on influencing factors on the plasma concentration‐to‐dose ratio	8
Long‐term outcomes after NORSE: Treatment with vagus nerve stimulation	8
Clemizole and trazodone are effective antiseizure treatments in a zebrafish model of STXBP1 disorder	8
The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia	8
Deep brain stimulation of the centromedian thalamic nucleus for the treatment of FIRES	8
Late diagnoses of Dravet syndrome: How many individuals are we missing?	8
A novel FAME1 repeat configuration in a European family identified using a combined genomics approach	8
Multimodal nocturnal seizure detection: Do we need to adapt algorithms for children?	8
Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients	8

Clinical and genetic characteristics of patients with Doose syndrome	8
Predictors of high school dropout, anxiety, and depression in genetic generalized epilepsy	8
Epilepsy in Morocco: Realities, pitfalls and prospects	8
Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal‐onset seizures with newly diagnosed or currently untreated recurrent epilepsy: A post ho	8
Performance of ECG‐based seizure detection algorithms strongly depends on training and test conditions	8
Astrocyte reactivity in a mouse model of SCN8A epileptic encephalopathy	8
Optimizing the surgical management of MRI‐negative epilepsy in the neuromodulation era	7
Epilepsy phenotype in individuals with chromosomal duplication encompassing FGF12	7
A disease concept model for STXBP1‐related disorders	7
Seizure‐related injuries in people with epilepsy: A cohort study from Saudi Arabia	7
Demonstrating the feasibility of digital health to support pediatric patients in South Africa	7
A complex systems view on the current hypotheses of epilepsy pharmacoresistance	7
ResectVol: A tool to automatically segment and characterize lacunas in brain images	7
Perampanel in real‐world clinical care of patients with epilepsy: Interim analysis of a phase IV study	7
Consistent safety and tolerability of Valtoco® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long‐term, open‐l	7
Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy	7
Clinical and genomic analysis of a large Chinese family with familial cortical myoclonic tremor with epilepsy and SAMD12 intronic repeat expansion	7
Efficacy and safety of adjunctive padsevonil in adults with drug‐resistant focal epilepsy: Results from two double‐blind, randomized, placebo‐controlled trials	7
Efficacy of long‐term adrenocorticotropic hormone therapy for West syndrome: A retrospective multicenter case series	7
Seizures in Sotos syndrome: Phenotyping in 49 patients	7
Impact of COVID‐19 pandemic on epilepsy care in Japan: A national‐level multicenter retrospective cohort study	6
Status epilepticus in the Canadian Arctic: A public health imperative hidden in plain sight	6
Use of suggestive seizure manipulation methods in the investigation of patients with possible psychogenic nonepileptic seizures—An international ILAE survey	6
Use of the International League Against Epilepsy (ILAE) 1989, 2010, and 2017 Classification of Epilepsy in children in a low‐resource setting: A hospital‐based cross‐sectional study	6
KETASER01 protocol: What went right and what went wrong	6
Multi‐omic strategies applied to the study of pharmacoresistance in mesial temporal lobe epilepsy	6
Sex‐based structural and functional MRI outcomes in the rat brain after soman (GD) exposure‐induced status epilepticus	6
Prevalence of epilepsy in Bangladesh: Results from a national household survey	6
Seizures induced in electroconvulsive therapy as a human epilepsy model: A comparative case study	6
Epilepsy in the Sanaga‐Mbam valley, an onchocerciasis‐endemic region in Cameroon: electroclinical and neuropsychological findings	6
Validation of semi‐automated anatomically labeled SEEG contacts in a brain atlas for mapping connectivity in focal epilepsy	6
Long‐term open‐label perampanel: Generalized tonic–clonic seizures in idiopathic generalized epilepsy	6
Potential role of FKBP5 single‐nucleotide polymorphisms in functional seizures	6
Effect of fenfluramine on seizures and comorbidities in SCN8A‐developmental and epileptic encephalopathy: A case series	6
Interpretable deep learning‐based hippocampal sclerosis classification	6
Interictal pattern on scalp electroencephalogram predicts excellent surgical outcome of epilepsy caused by focal cortical dysplasia	5
Intracranial monitoring contributes to seizure freedom for temporal lobectomy patients with nonconcordant preoperative data	5
Factors not considered in the study of drug‐resistant epilepsy: Psychiatric comorbidities, age, and gender	5
Epilepsy surgery in early infancy: A retrospective, multicenter study	5
Epilepsy duration is an independent factor for electrocardiographic changes in pediatric epilepsy	5
Drug‐resistant epilepsy and the hypothesis of intrinsic severity: What about the high‐frequency oscillations?	5
Factors not considered in the study of drug‐resistant epilepsy: Drug‐resistant epilepsy: Assessment of neuroinflammation	5
Knowledge and attitude toward epilepsy among the final and semi‐final years medical students at University of Bahri, Sudan	5
Seizure features and outcomes in 50 children with GATOR1 variants: A retrospective study, more favorable for epilepsy surgery	5
Familial neonatal seizures caused by the Kv7.3 selectivity filter mutation T313I	5
Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force	5
Status of epilepsy in the tropics: An overlooked perspective	5
Brain glycogen content is increased in the acute and interictal chronic stages of the mouse pilocarpine model of epilepsy	5
The goal of explaining black boxes in EEG seizure prediction is not to explain models' decisions	5
A European pilot study in Dravet Syndrome to delineate what really matters for the patients and families	5
Experience with the ketogenic diet in premature neonates	5
A study of factors influencing self‐stigma in people with epilepsy: A nationwide online questionnaire survey in Japan	5
Sudden unexpected death in epilepsy: A critical view of the literature	5
Early preclinical plasma protein biomarkers of brain trauma are influenced by early seizures and levetiracetam	5
A novel possible familial cause of epilepsy of infancy with migrating focal seizures related to SZT2 gene variant	5
The Efficacy, Safety, and Outcomes of Brain‐responsive Neurostimulation (RNS® System) therapy in older adults	5
Recurrence risk after a first remote symptomatic seizure in adults: Epilepsy or not?	5
Analyses of seizure responses supportive of a novel trial design to assess efficacy of antiepileptic drugs in infants and young children with epilepsy: Post hoc analyses of pediatric levetiracetam and	5
Sleep architecture in drug‐naïve adult patients with epilepsy: Comparison between focal and generalized epilepsy	5
A cross‐sectional study of COVID‐19 vaccination patterns among patients with epilepsy in Hong Kong	5
Neurodevelopmental origins of self‐limiting rolandic epilepsy: Systematic review of MR imaging studies	5
A new rapid titration protocol for lamotrigine that reduces the risk of skin rash	5
Antiepileptogenesis after stroke—trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate	4
How accurately do adult patients report their absence seizures?	4
Are we responding effectively to bone mineral density loss and fracture risks in people with epilepsy?	4
Frontal disconnection surgery for drug‐resistant epilepsy: Outcome in a series of 16 patients	4
Impact of theCOVID‐19 pandemic on people with epilepsy: Findings from theUSarm of theCOV‐Estudy	4
The National Comprehensive Governance for epilepsy prevention and control in China	4
Complete hemispherotomy leads to lateralized functional organization and lower level of consciousness in the isolated hemisphere	4
Drug‐resistant epilepsy: Drug target hypothesis and beyond the receptors	4
Status epilepticus and early development: Neuronal injury, neurodegeneration, and their consequences	4
Termination of seizures by ictal transcranial focal cortex stimulation	4
Delta brush variant: A novel ictal EEG pattern in anti‐NMDAR encephalitis	4
An online tool for information to women with epilepsy and therapeutic drug monitoring in pregnancy: Design and pilot study	4
Combined use of the ketogenic diet and vagus nerve stimulation in pediatric drug‐resistant epilepsy	4
Cardiac structural and functional abnormalities in epilepsy: A systematic review and meta‐analysis	4
Comorbid seizure reduction after pallidothalamic tractotomy for movement disorders: Revival of Jinnai’s Forel‐H‐tomy	4
Clinical characteristics and outcomes after new‐onset seizure among Zambian children with HIV during the antiretroviral therapy era	4
Recurrence rates and risk factors for seizure recurrence following antiseizure medication withdrawal in adolescent patients with genetic generalized epilepsy	4
Treatment of cholinergic‐induced status epilepticus with polytherapy targeting GABA and glutamate receptors	4

Human herpesvirus 6 and epilepsy	4
Infantile‐onset myoclonic developmental and epileptic encephalopathy: A new RARS2 phenotype	4
FKBP5 blockade may provide a new horizon for the treatment of stress‐associated disorders: An in‐silico study	4
Risk factors that predict delayed seizure detection on continuous electroencephalogram (cEEG) in a large sample size of critically ill patients	4
Ordinal regression increases statistical power to predict epilepsy surgical outcomes	4
Microglia and status epilepticus in the immature brain	4